Global Iron-Chelating Drug Market Research Report 2016

October 2016 | 101 pages | ID: G4A4C1A6F4AEN
QYResearch

Abstracts

Notes:

Production, means the output of Iron-Chelating Drug

Revenue, means the sales value of Iron-Chelating Drug

This report studies Iron-Chelating Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Actavis, Inc. (US)
• AMAG Pharmaceuticals, Inc. (US)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• Galenica Ltd. (Switzerland)
• Vifor Pharma Ltd. (Switzerland)
• Luitpold Pharmaceuticals, Inc. (US)
• American Regent, Inc. (US)
• Pharmacosmos A/S (Denmark)
• Sanofi US (US)
• Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Iron-Chelating Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Iron-Chelating Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Iron-Chelating Drug Market Research Report 2016

1 IRON-CHELATING DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Iron-Chelating Drug
1.2 Iron-Chelating Drug Segment by Type
  1.2.1 Global Production Market Share of Iron-Chelating Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Iron-Chelating Drug Segment by Application
  1.3.1 Iron-Chelating Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Iron-Chelating Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Iron-Chelating Drug (2011-2021)

2 GLOBAL IRON-CHELATING DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Iron-Chelating Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Iron-Chelating Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Iron-Chelating Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Iron-Chelating Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Iron-Chelating Drug Market Competitive Situation and Trends
  2.5.1 Iron-Chelating Drug Market Concentration Rate
  2.5.2 Iron-Chelating Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL IRON-CHELATING DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Iron-Chelating Drug Production and Market Share by Region (2011-2016)
3.2 Global Iron-Chelating Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL IRON-CHELATING DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Iron-Chelating Drug Consumption by Regions (2011-2016)
4.2 North America Iron-Chelating Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Iron-Chelating Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Iron-Chelating Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Iron-Chelating Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Iron-Chelating Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Iron-Chelating Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL IRON-CHELATING DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Iron-Chelating Drug Production and Market Share by Type (2011-2016)
5.2 Global Iron-Chelating Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Iron-Chelating Drug Price by Type (2011-2016)
5.4 Global Iron-Chelating Drug Production Growth by Type (2011-2016)

6 GLOBAL IRON-CHELATING DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Iron-Chelating Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Iron-Chelating Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL IRON-CHELATING DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Actavis, Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Iron-Chelating Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Actavis, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 AMAG Pharmaceuticals, Inc. (US)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Iron-Chelating Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 AMAG Pharmaceuticals, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Fresenius Medical Care AG & Co. KGaA (Germany)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Iron-Chelating Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Fresenius Medical Care AG & Co. KGaA (Germany) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Galenica Ltd. (Switzerland)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Iron-Chelating Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Galenica Ltd. (Switzerland) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Vifor Pharma Ltd. (Switzerland)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Iron-Chelating Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Vifor Pharma Ltd. (Switzerland) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Luitpold Pharmaceuticals, Inc. (US)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Iron-Chelating Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Luitpold Pharmaceuticals, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 American Regent, Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Iron-Chelating Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 American Regent, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Pharmacosmos A/S (Denmark)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Iron-Chelating Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Pharmacosmos A/S (Denmark) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Sanofi US (US)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Iron-Chelating Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Sanofi US (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Takeda Pharmaceutical Company Limited (Japan)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Iron-Chelating Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Takeda Pharmaceutical Company Limited (Japan) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 IRON-CHELATING DRUG MANUFACTURING COST ANALYSIS

8.1 Iron-Chelating Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Iron-Chelating Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Iron-Chelating Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Iron-Chelating Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IRON-CHELATING DRUG MARKET FORECAST (2016-2021)

12.1 Global Iron-Chelating Drug Production, Revenue Forecast (2016-2021)
12.2 Global Iron-Chelating Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Iron-Chelating Drug Production Forecast by Type (2016-2021)
12.4 Global Iron-Chelating Drug Consumption Forecast by Application (2016-2021)
12.5 Iron-Chelating Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Iron-Chelating Drug
Figure Global Production Market Share of Iron-Chelating Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Iron-Chelating Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Iron-Chelating Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Iron-Chelating Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Iron-Chelating Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Iron-Chelating Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Iron-Chelating Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Iron-Chelating Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Iron-Chelating Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Iron-Chelating Drug Production of Key Manufacturers (2015 and 2016)
Table Global Iron-Chelating Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Iron-Chelating Drug Production Share by Manufacturers
Figure 2016 Iron-Chelating Drug Production Share by Manufacturers
Table Global Iron-Chelating Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Iron-Chelating Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Iron-Chelating Drug Revenue Share by Manufacturers
Table 2016 Global Iron-Chelating Drug Revenue Share by Manufacturers
Table Global Market Iron-Chelating Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Iron-Chelating Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Iron-Chelating Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Iron-Chelating Drug Product Type
Figure Iron-Chelating Drug Market Share of Top 3 Manufacturers
Figure Iron-Chelating Drug Market Share of Top 5 Manufacturers
Table Global Iron-Chelating Drug Production by Regions (2011-2016)
Figure Global Iron-Chelating Drug Production and Market Share by Regions (2011-2016)
Figure Global Iron-Chelating Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Iron-Chelating Drug Production Market Share by Regions
Table Global Iron-Chelating Drug Revenue by Regions (2011-2016)
Table Global Iron-Chelating Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Iron-Chelating Drug Revenue Market Share by Regions
Table Global Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Iron-Chelating Drug Consumption Market by Regions (2011-2016)
Table Global Iron-Chelating Drug Consumption Market Share by Regions (2011-2016)
Figure Global Iron-Chelating Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Iron-Chelating Drug Consumption Market Share by Regions
Table North America Iron-Chelating Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Iron-Chelating Drug Production, Consumption, Import & Export (2011-2016)
Table China Iron-Chelating Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Iron-Chelating Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Iron-Chelating Drug Production, Consumption, Import & Export (2011-2016)
Table India Iron-Chelating Drug Production, Consumption, Import & Export (2011-2016)
Table Global Iron-Chelating Drug Production by Type (2011-2016)
Table Global Iron-Chelating Drug Production Share by Type (2011-2016)
Figure Production Market Share of Iron-Chelating Drug by Type (2011-2016)
Figure 2015 Production Market Share of Iron-Chelating Drug by Type
Table Global Iron-Chelating Drug Revenue by Type (2011-2016)
Table Global Iron-Chelating Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Iron-Chelating Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Iron-Chelating Drug by Type
Table Global Iron-Chelating Drug Price by Type (2011-2016)
Figure Global Iron-Chelating Drug Production Growth by Type (2011-2016)
Table Global Iron-Chelating Drug Consumption by Application (2011-2016)
Table Global Iron-Chelating Drug Consumption Market Share by Application (2011-2016)
Figure Global Iron-Chelating Drug Consumption Market Share by Application in 2015
Table Global Iron-Chelating Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Iron-Chelating Drug Consumption Growth Rate by Application (2011-2016)
Table Actavis, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis, Inc. (US) Iron-Chelating Drug Market Share (2011-2016)
Table AMAG Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AMAG Pharmaceuticals, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure AMAG Pharmaceuticals, Inc. (US) Iron-Chelating Drug Market Share (2011-2016)
Table Fresenius Medical Care AG & Co. KGaA (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fresenius Medical Care AG & Co. KGaA (Germany) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Fresenius Medical Care AG & Co. KGaA (Germany) Iron-Chelating Drug Market Share (2011-2016)
Table Galenica Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galenica Ltd. (Switzerland) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Galenica Ltd. (Switzerland) Iron-Chelating Drug Market Share (2011-2016)
Table Vifor Pharma Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vifor Pharma Ltd. (Switzerland) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Vifor Pharma Ltd. (Switzerland) Iron-Chelating Drug Market Share (2011-2016)
Table Luitpold Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Luitpold Pharmaceuticals, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Luitpold Pharmaceuticals, Inc. (US) Iron-Chelating Drug Market Share (2011-2016)
Table American Regent, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table American Regent, Inc. (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure American Regent, Inc. (US) Iron-Chelating Drug Market Share (2011-2016)
Table Pharmacosmos A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharmacosmos A/S (Denmark) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pharmacosmos A/S (Denmark) Iron-Chelating Drug Market Share (2011-2016)
Table Sanofi US (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi US (US) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi US (US) Iron-Chelating Drug Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Company Limited (Japan) Iron-Chelating Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited (Japan) Iron-Chelating Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Iron-Chelating Drug
Figure Manufacturing Process Analysis of Iron-Chelating Drug
Figure Iron-Chelating Drug Industrial Chain Analysis
Table Raw Materials Sources of Iron-Chelating Drug Major Manufacturers in 2015
Table Major Buyers of Iron-Chelating Drug
Table Distributors/Traders List
Figure Global Iron-Chelating Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Iron-Chelating Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Iron-Chelating Drug Production Forecast by Regions (2016-2021)
Table Global Iron-Chelating Drug Consumption Forecast by Regions (2016-2021)
Table Global Iron-Chelating Drug Production Forecast by Type (2016-2021)
Table Global Iron-Chelating Drug Consumption Forecast by Application (2016-2021)